Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
68 Cards in this Set
- Front
- Back
Simvastatin (Zocor)
|
inhibits HMG-CoA reductase
SE: muscle breakdown |
|
Niacin (Niacor)
|
inhibits diacylglycerol acyl-transferase 2
SE: flushing/rashes |
|
Clofibrate (N/A)
|
PPAR-alpha agonist
SE: myopathy, arrhythmias |
|
Fenofibrate (tricor)
|
PPAR-alpha agonist
SE: myopathy, arrhythmias |
|
colestipol (colestid)
|
bind bile acids
SE: GI effects |
|
Ezetimibe (Zetia)
|
inhibits cholesterol transporter NPC1L1
SE: GI effects used with statins as last resort Tx |
|
Betahistine (Serc)
|
activates HI receptors
use: vertigo SE: headache/nausea |
|
Dimenhydrinate (Dramamine)
|
inhibits H1 receptors
use: allergy generally SE: sedation |
|
Diphenhydramine (Benadryl)
|
inhibits H1 receptors
use: allergy generally SE: sedation |
|
Hydroxyzine (Atarax)
|
inhibits H1 receptors
use: allergy generally SE: sedation |
|
Bromopheniramine (Dimatapp)
|
inhibits H1 receptors
use: allergy generally SE: sedation |
|
Fexofenadine (Allegra)
|
inhibits H1 receptors
use: allergy generally SE: sedation |
|
Bicarbonates (Alka-Seltzer)
|
neutralizes gastric acid
use: GERD, s/a SE: metabolic alkalosis |
|
aluminum hydroxides (Gaviscon)
|
neutralizes gastric acid
use: GERD, s/a SE: GI |
|
Ranitidine (Zantac)
|
blocks H2-receptors
use: GERD, peptic ulcer, h/b SE: GI |
|
Famotidine (Pepcid)
|
blocks H2-receptors
use: GERD, peptic ulcer, h/b SE: GI |
|
Omeprazol (Prilosec)
|
blocks H/K ATPase pump
use: GERD, peptic ulcer, h/b SE: GI |
|
Pantoprazole (Protium)
|
blocks H/K ATPase pump
use: GERD, peptic ulcer, h/b SE: GI |
|
Sucralfate (Carafate)
|
forms protective barrier
use: ulcers, GI bleeding SE: GI |
|
Misoprostol (Cytotec)
|
prostaglandin receptor agonist
use: NSAID-induced ulcers SE: GI |
|
Bismuth subsalicylate (Pepto Bismol)
|
forms protective barrier
use: ulcers, diarrhea SE: Reye's syndrome |
|
weak bases are ionized, T/F?
|
True, thus more polar and more water soluble
|
|
weak acids are ionized, T/F?
|
False. Weak acids are not ionized and so are less water soluble when they are protonated
|
|
RNH3+ <-> RNH2 + H+
Which is more water soluble? |
RNH3+; it is a protonated weak base and it is charged; RNH2 is an unprotonated weak base that is uncharged and more lipid soluble
|
|
RCOOH <-> RCOO- + H+
Which is more water soluble? |
RCOO- because it is an unprotonated weak acid and charged; RCOOH is a protonated weak acid that is uncharged and thsu more lipid soluble
|
|
permeation
|
movement of drug molecules into biologic environment
-aqueous diffusion -lipid diffusion -transport by special carriers -endocytosis/pinocytosis |
|
the smaller the EC50 the greater the potency of the drug, T/F
|
T
|
|
What is the Kd?
|
the concentration of the drug required to bind 50% of the receptor sites; measures affinity of drug for its binding site on receptor
|
|
The smaller the Kd the greater the affinity of the drug for its receptor; T/F?
|
T
|
|
What is EC50?
|
in graded dose response curves, the concentration or dose required that produces 50% of max
|
|
competitive antagonist
|
binds the receptor in a reversible way without activating the effector system of that receptor (curve will shift to the right-more drug needed to reach max); Effect can be overcome by adding more agonist; competitive antagonists increase the ED50 (agonist appears less potent)
|
|
irreversible antagonist
|
causes a downward shift of the max with no shift to the curve on the dose axis unless spare receptors are present (reduces max)
|
|
physiological antagonist
|
drug that binds to a different receptor producing an effect opposite to that produced by drug its antagonizing
|
|
what if you find that the EC50 of a drug is smaller than the Kd?
|
you have spare receptors
|
|
Pharmacokinetics is the study of the actions of the body on drugs.
What are the 4 main concepts of pharmacokinetics? |
MADE
M: metabolism A: absorbtion D: distribution E: excretion |
|
What is bioavailibitliy?
how is it measured? |
bioavailability is the measure of drug in the systemic circulation.
measured by area under the curve (AUC) of blood concentration of drug over time. |
|
What is first pass metabolism? (aka presystemic elimination)
|
The elimination of drug that occures before it reaches systemic circulation. (Eg. oral meds in gut/liver)
|
|
What are the 5 general ways drugs pass cell membranes? (2 passive and 2 active)
|
Passive
1) simple diffusion 2) facilitated diffusion (through specific/nonspecific transporters) Active 1) pumps 2) pinocytosis |
|
What form of the drug penetrates cell membranes best (protonated/unprotonated)?
1) weak bases 2) weak acids |
Penetrate cell walls best
1) weak bases : unprotonated 2) weak acids : protonated |
|
At a LOW pH environment like the stomach, what type of drug (weak acid or weak base) is more able to absorb into cells?
|
At LOW ph : weak acids become protonated and are more able to absorb into cells
weak bases become protonated and are LESS able to be absorbed. |
|
In a relatively neutral pH (like blood or the body's aqueous humor), which type of drug is able to be absorbed into cells more readily, weak acid or weak base?
|
WEAK ACID drugs are able to absorb more readily than weak base drugs in neutral pH becasue at pH 7:
weak acids become unprotonated (become uncharged) weak bases become protonated (become charged) |
|
Tissue distribution of a drug depends on what two factors?
|
1) blood perfusion of the tissue
2) the tissue/blood partition ratio (Kp). Kp= Ctissue/Cven-blood (at equilibrium) |
|
Rank the following tissues in order of most partition ratio to least partition ractio: Fat, Kidney, Brain
|
MOST to LEAST partition ratio:
1) Kidney 2) Brain 3) Fat |
|
What are 5 unique characteristics of CNS capillary endothelia that make it different than most capillary endothelia?
|
1) Tight intercellular junctions
2) Lacks fenestrations 3) minimal pinocytosis 4) drug metabolizing enzymes 5) endothelial drug transporters (efflux into the blood) 6) abundant mitochondria (power efflux pumps) |
|
What is VOLUME OF DISTRIBUTION (Vd)?
|
Given a set quantity of drug:
the volume of fluid the drug would need to be dissolved in to match the concentration of the drug in given volume of plasma. |
|
How do you experimentally measure (calculate) the Vd for a drug?
|
1) Inject someone with a measured dose of a drug
2) plot plasma concentratio of drug 3) extrapolate time-zero plasma concentration 4) divide the dose by time-zero pasma concentration |
|
There are two phases of drug metabolism. what happens in phase 1?
|
Drugs are FUNCTIONALIZED, commonly by oxidaiton, reduction or hydrolysis
|
|
There are two phases of drug metabolism. What happens in phase 2?
|
The products of phase 1 are CONJUGATED, commonly with endogenous molecules like glucuronic acid.
|
|
What is metabolic inactivation?
|
converting a pharmacologically active, lipophilic drug to an inactive hydrophilic metabolite (conjugate) which is readily excreted.
|
|
volume of distribution
|
the ratio of the amount of a drug in the body to its concentration in the plasma or blood
Vd= amt of drug (body)/plasma drug concent. |
|
What is metabolic bioactivation?
|
changing a "prodrug" into its pharmacoliogically active form through a metabolic reation
|
|
clearance
|
the ratio of the rate of elimination of a drug to its concentration in plasma or blood
CL=rate of el of drug/plasma drug concent. |
|
half-life
|
time it takes for the amount or concentration of a drug to fall to 50% of an earlier measurement. For drugs eliminated by first order kinetics, this number is a constant regardless of concentration. Half life is not a constant and therefore not particularly useful for drugs eliminated by zero order kinetics (ethanol)
t1/2= 0.693xVd/CL |
|
what is metabolic toxicity?
example? |
Toxic products of drug metabolism.
eg. acetaminophen through CYP2E1 metabolism in liver |
|
bioavailaibility
|
the fraction (or %) of the administered dose of a drug that reaches the systemic circulation.
|
|
AUC
|
the graphic area under a plot of drug concentration in plasma versus time after a single dose of a drug or during a single dosing interval; the AUC is imp for calculating the bioavailability of a drug given by any route other than IV
|
|
Peak and trough concentration
|
the max and min drug concentrations in plasma or blood measured during cycles of repeated dosing
|
|
minimum effective concentrations (MEC)
|
the plasma concentration below which a patient's response is too small for therapeutic benefit
|
|
first pass effect
|
the elimination of drug that occurs after administration but before it reaches the systemic circ
|
|
steady state
|
in pharmacokinetics the condition in which the average total amount of drug in the body does not change over multiple dosing intervals (rate of drug input equals the rate of elimination)
|
|
extraction
|
the fraction of adrug in the plasma that is removed by an organ as it passes through that organ
|
|
bioequivalence
|
the equivalence of blood concentrations of two preparations of the same drug measured over time; if the concentration time plots for hte two preparations are nearly superimposable (within certain statistical limits) teh preparations are said to be bioequivalent; one preparation may be safely substituted for the other. this parameter is used in determining the safety and efficacy of generic drugs
|
|
biodisposition
|
often used as a synonym for pharmacokinetics; the processes of drug absorption, distribution and elimination
|
|
What families of P450 enzyme (CYP gene) are responsible for a major portion of drug metabolism?
|
CYP1-3
|
|
What are three major human liver P450s that metabolize....
1) weakly acidic drugs 2) weakly basic drugs 3) practically everything else |
1) CYP2C2 : weakly acidic drugs
2) CYP2D6 : weakly basic drugs 3) CYP3A4 : practically everything else |
|
What are three major reaction types that occure during phase 1 metabolism?
|
1) oxidation at C, N, S ceneters
2) Reductive Rxns at C, N, S centers 3)Hydrolysis Rxns (of esters and amines) |
|
What is enzyme induction?
example? |
Inc. in steady-state concentrations of an enzyme due to stimulus.
eg (1) inc. in CYP2E1 concentration due to alcoholism (2) Rifampicin induction of P450 -> inc. metabolism (lowers efficacy) of oral contraceptives/warfarin |
|
What is enzyme inhibition?
eg? |
Inhibition is loss or dec. of drug-metabolizing enzyme due to stimulus
eg. grapefruit juice degrades CYP3A4, inhibiting metabolic activation of Felodipine (dihydropyridine Ca channel antagonist) preventing its uptake (higher plasma concentrations) |